Abstract:Oral submucous fibrosis (OSF) is a chronic oral mucosal disease. The pathological changes of OSF include epithelial damage and subepithelial matrix fibrosis. This study aimed to reveal the epithelial injury mechanism of OSF. A histopathological method was used to analyze oral mucosal tissue from OSF patients and OSF rats. The expression of PDE12 in the oral epithelium was analyzed by immunohistochemistry. The epithelial-mesenchymal transition (EMT) and tight junction proteins in arecoline-treated HOKs were explored by western blotting. Epithelial leakage was assessed by transepithelial electrical resistance and lucifer yellow permeability. The expression of PDE12 and the mitochondrial morphology, mitochondrial permeability transition pore opening, mitochondrial membrane potential, and mitochondrial reactive oxygen species (mtROS) were evaluated in arecoline-induced HOKs. Oxidative phosphorylation (OXPHOS) complexes and ATP content were also explored in HOKs. The results showed significant overexpression of PDE12 in oral mucosal tissue from OSF patients and rats. PDE12 was also overexpressed and aggregated in mitochondria in arecoline-induced HOKs, resulting in dysfunction of OXPHOS and impaired mitochondrial function. An EMT, disruption of tight junctions with epithelial leakage, and extracellular matrix remodeling were also observed. PDE12 overexpression induced by PDE12 plasmid transfection enhanced the mtROS level and interfered with occludin protein localization in HOKs. Interestingly, knockdown of PDE12 clearly ameliorated arecoline-induced mitochondrial dysfunction and epithelial barrier dysfunction in HOKs. Therefore, we concluded that overexpression of PDE12 impaired mitochondrial OXPHOS and mitochondrial function and subsequently impaired epithelial barrier function, ultimately leading to OSF. We suggest that PDE12 may be a new potential target against OSF.

Senescent Epithelial Cells Remodel the Microenvironment for the Progression of Oral Submucous Fibrosis Through Secreting TGF-(31

Exosomal miR-17-5p derived from epithelial cells is involved in aberrant epithelium-fibroblast crosstalk and induces the development of oral submucosal fibrosis

Exosomal Mir-17-5p Derived from Epithelial Cells is Involved in Aberrant Epithelium-Fibroblast Cross-Talk and Induces the Development of Oral Submucosal Fibrosis

Experimental Study on TGF‐β1‐mediated CD147 Expression in Oral Submucous Fibrosis

Proliferative Ability and Accumulation of Cancer Stem Cells in Oral Submucous Fibrosis Epithelium.

Emerging role of cellular senescence in the pathogenesis of oral submucous fibrosis and its malignant transformation

Identification of a BRAF/PA28γ/MEK1 Signaling Axis and Its Role in Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis

Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation

Fibrotic Matrix Induces Mesenchymal Transformation of Epithelial Cells in Oral Submucous Fibrosis

YAP-Induced Endothelial-Mesenchymal Transition in Oral Submucous Fibrosis.

Mir-203 Inhibits Arecoline-Induced Epithelial-Mesenchymal Transition by Regulating Secreted Frizzled-Related Protein 4 and Transmembrane-4 L Six Family Member 1 in Oral Submucous Fibrosis

Role of integrin alpha_1 in the pathogenesis of oral submucous fibrosis

Autophagy Mediates Oral Submucous Fibrosis.

DPSCs regulate epithelial-T cell interactions in oral submucous fibrosis

Overexpression of DEC1 in the Epithelium of OSF Promotes Mesenchymal Transition Via Activating FAK/Akt Signal Axis.

Role of the Arecoline/yap1/bmp4 Pathway in Promoting Endothelial-Mesenchymal Transition in Oral Submucous Fibrosis

Cytokines secreted by arecoline activate fibroblasts that affect the balance of TH17 and Treg

PDE12 Disrupts Mitochondrial Oxidative Phosphorylation and Mediates Mitochondrial Dysfunction to Induce Oral Mucosal Epithelial Barrier Damage in Oral Submucous Fibrosis.

Stromal Thrombospondin 1 Suppresses Angiogenesis in Oral Submucous Fibrosis

Interleukin‐13 contributes to the occurrence of oral submucosal fibrosis

Evaluation of stromal myofibroblasts in oral submucous fibrosis and its malignant transformation: An immunohistochemical study